M&A Deal Summary

Biocomposites Acquires Renovos

On July 5, 2023, Biocomposites acquired medical products company Renovos

Acquisition Highlights
  • This is Biocomposites’ 1st transaction in the Medical Products sector.
  • This is Biocomposites’ 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2023-07-05
Target Renovos
Sector Medical Products
Buyer(s) Biocomposites
Deal Type Add-on Acquisition

Target

Renovos

Southampton, United Kingdom
Renovos is an international medical device company that engineers, manufactures, and markets products for use in infection management in bone and soft tissue. The company has global operations across Europe, USA, Canada, China, and India. Its products regenerate bone and target infection risks across a variety of specialties, including musculoskeletal infection, orthopedics, trauma, spine, foot and ankle, podiatry, and sports injuries. Renovos is based in Southampton, England.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Biocomposites

Wilmington, North Carolina, United States

Category Company
Founded 1997
Sector Life Science
DESCRIPTION

Biocomposites is a manufacturer and marketer of calcium compound biologics. Biocomposites is singularly focused on the development of innovative calcium compounds for surgical use. Their bone graft matrices can be used in the presence of infection for regenerating bone and managing dead space in a range of orthopedic procedures. Biocomposites sells directly to hospitals and through independent distributors, with the United States representing its largest market. Biocomposites was founded in 1997 and is based in Wilmington, North Carolina.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2023 M&A 1 of 1